Sign in

CIK 0001385818

  • Non-accelerated filer
  • Smaller reporting company

AYTU BIOPHARMA, INC

Sign in to watch
Ticker
AYTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
470883144
Phone
+1 720-437-6580
Business address
7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
Former names
AYTU BIOSCIENCE, INC, Rosewind CORP
  1. 4 Open-market buy Chief Financial Officer bought 66,600 shares at $0.45 ($29,970)
  2. 4 Open-market buy Chief Operating Officer bought 226,105 shares at $0.45 ($101,747)
  3. 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 50,000 shares (grant or award)
  6. 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
  7. 4 Grant or award Director acquired 50,000 shares (grant or award)
  8. 4 Grant or award Director acquired 50,000 shares (grant or award)
  9. 4 Grant or award Chief Operating Officer acquired 100,000 shares (grant or award)
  10. 4 Grant or award Director acquired 50,000 shares (grant or award)
  11. 4 Grant or award Chief Operating Officer acquired 1,666,667 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 1,666,667 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4/A Exercise or conversion Director acquired 37,083 shares (option exercise)

Page 7 of 10 · 187 filings